Moneycontrol Be a Pro
Get App
you are here: HomeNewsBusiness
Last Updated : Aug 29, 2018 08:41 PM IST | Source: PTI

Laurus Labs gets USFDA nod for diabetes drug

The company has received approval from United States Food and Drug Administration (USFDA) for Metformin hydrochloride tablets USP in the strengths of 500 mg, 850 mg and 1,000 mg, Laurus Labs said in a BSE filing.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm Laurus Labs today said it has received approval from the US health regulator for its Metformin hydrochloride tablets used for treatment of diabetes.

The company has received approval from United States Food and Drug Administration (USFDA) for Metformin hydrochloride tablets USP in the strengths of 500 mg, 850 mg and 1,000 mg, Laurus Labs said in a BSE filing.

The tablets are generic versions of Bristol-Myers Squibb Company's Glucophage tablets in the same strengths, it added.

Close

The product and API will be commercialised from company's Unit 2 located at Atchutapuram, Visakhapatnam in Andhra Pradesh, Laurus Labs said.

Shares of Laurus Labs today closed at Rs 438.70 per scrip on BSE, down 0.44 per cent from its previous close.

The Great Diwali Discount!
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .
First Published on Aug 29, 2018 08:38 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant